Fujio Asanuma

544 citations

20 papers · 472 indexed · h-index 12

Co-authors: Akinori Arimura Kiyoshi Yasui Mitsuaki Ohtani Junji Kishino Atsushi Kurosawa Shinji Kakudo Hiroshi Hasegawa Hitoshi Arita
Topics: Asthma and respiratory diseases (14 papers)Inflammatory mediators and NSAID effects (11 papers)Respiratory and Cough-Related Research (4 papers)
Cited by: Immunology and Allergy Pharmacology Physiology
Journals: Journal of Allergy and Clinical Immunology Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: Japan United States

In The Last Decade

Fujio Asanuma

20 papers receiving 449 citations

Peers

Countries citing papers authored by Fujio Asanuma

Since Specialization

Citations

This map shows the geographic impact of Fujio Asanuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fujio Asanuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fujio Asanuma more than expected).

Fields of papers citing papers by Fujio Asanuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fujio Asanuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fujio Asanuma. The network helps show where Fujio Asanuma may publish in the future.

Co-authorship network of co-authors of Fujio Asanuma

This figure shows the co-authorship network connecting the top 25 collaborators of Fujio Asanuma. A scholar is included among the top collaborators of Fujio Asanuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fujio Asanuma. Fujio Asanuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of the potent and selective DP1 receptor antagonist, asapiprant (S-555739), in animal models of allergic rhinitis and allergic asthma 2015 ·European Journal of Pharmacology ·Go Takahashi,Fujio Asanuma,Noriko Suzuki,(unknown),Shingo Sakamoto,Akira Kugimiya,Yasuhiko Tomita,Goro Kuwajima,William M. Abraham,Masashi Deguchi,Akinori Arimura,Michitaka Shichijo	17
2	Prostanoid DP receptor antagonists suppress symptomatic asthma-like manifestation by distinct actions from a glucocorticoid in rats 2011 ·European Journal of Pharmacology ·(unknown),Michitaka Shichijo,Minoru Ikeda,Motoji Kitaura,Junji Tsuchida,Fujio Asanuma,Toru Yanagimoto,(unknown),Kinichi Imura,Kiyoshi Yasui,Akinori Arimura	9
3	Ceramide kinase is not essential but might act as an Ca2+-sensor for mast cell activation 2010 ·Prostaglandins & Other Lipid Mediators ·Susumu Mitsutake,(unknown),(unknown),(unknown),Fujio Asanuma,Morio Nagira,Masashi Deguchi,(unknown),(unknown),Yuichi Inagaki,Masako Sugiura,Takafumi Kohama,Yasuyuki Igarashi	7
4	Contribution of prostaglandin D2 via prostanoid DP receptor to nasal hyperresponsiveness in guinea pigs repeatedly exposed to antigen 2007 ·European Journal of Pharmacology ·Kiyoshi Yasui,Fujio Asanuma,(unknown),Michitaka Shichijo,Masashi Deguchi,Akinori Arimura	9
5	Synthesis and Biological Activity of Various Derivatives of a Novel Class of Potent, Selective, and Orally Active Prostaglandin D₂Receptor Antagonists. 1. Bicyclo[2.2.1]heptane Derivatives 2003 ·Journal of Medicinal Chemistry ·Susumu Mitsumori,Tatsuo Tsuri,Tsunetoshi Honma,(unknown),Toshihiko Okada,Hiroshi Hashizume,Masanao Inagaki,Akinori Arimura,Kiyoshi Yasui,Fujio Asanuma,Junji Kishino,Mitsuaki Ohtani	32
6	Synthesis and Biological Activity of Various Derivatives of a Novel Class of Potent, Selective, and Orally Active Prostaglandin D₂ Receptor Antagonists. 2. 6,6-Dimethylbicyclo[3.1.1]heptane Derivatives 2003 ·Journal of Medicinal Chemistry ·Susumu Mitsumori,Tatsuo Tsuri,Tsunetoshi Honma,(unknown),Toshihiko Okada,Hiroshi Hashizume,(unknown),Masanao Inagaki,Akinori Arimura,Kiyoshi Yasui,Fujio Asanuma,Junji Kishino,Mitsuaki Ohtani	53
7	Effects of leukotriene B 4 receptor antagonist, LY293111Na, on antigen-induced bronchial hyperresponsiveness and leukocyte infiltration in sensitized guinea pigs 2001 ·Inflammation Research ·Fujio Asanuma,(unknown),Akinori Arimura,(unknown),J H Fleisch,Yoshifumi Hori	16
8	Inhibitory Effect of a TP-Receptor Antagonist, S-1452, on Antigen-Induced Nasal Plasma Exudation in Guinea Pig Model for Allergic Rhinitis 2001 ·Pharmacology ·(unknown),Fujio Asanuma,Akinori Arimura	8
9	Prevention of Allergic Inflammation by a Novel Prostaglandin Receptor Antagonist, S-5751 2001 ·Journal of Pharmacology and Experimental Therapeutics ·Akinori Arimura,Kiyoshi Yasui,Junji Kishino,Fujio Asanuma,Hiroshi Hasegawa,Shinji Kakudo,Mitsuaki Ohtani,Hitoshi Arita	123
10	Involvement of Thromboxane A<sub>2</sub> in Antigen-Induced Nasal Blockage in Guinea Pigs 1997 ·International Archives of Allergy and Immunology ·Kiyoshi Yasui,Fujio Asanuma,(unknown),(unknown)	23
11	Bicyclo[2.2.1]heptane and 6,6-Dimethylbicyclo[3.1.1]heptane Derivatives: Orally Active, Potent, and Selective Prostaglandin D₂ Receptor Antagonists 1997 ·Journal of Medicinal Chemistry ·Tatsuo Tsuri,Tsunetoshi Honma,(unknown),Toshihiko Okada,Hiroshi Hashizume,Susumu Mitsumori,Masanao Inagaki,Akinori Arimura,Kiyoshi Yasui,Fujio Asanuma,Junji Kishino,Mitsuaki Ohtani	28
12	Contribution of thromboxane A₂ to the antigen‐induced immediate asthmatic response mediated by IgG1 antibody by augmentation of bronchial responsiveness in guinea‐pigs 1994 ·British Journal of Pharmacology ·Akinori Arimura,Fujio Asanuma,Atsushi Kurosawa,Minoru Harada	7
13	Effect of the selective thromboxane A2 receptor antagonist, S-1452, on antigen-induced sustained bronchial hyperresponsiveness 1994 ·European Journal of Pharmacology ·Akinori Arimura,Fujio Asanuma,Yōko Matsumoto,Atsushi Kurosawa,Hirokuni Jyoyama,Hiroichi Nagai	17
14	Involvement of thromboxane A2 in bronchial hyperresponsiveness but not lung inflammation induced by bacterial lipopolysaccharide in guinea pigs 1993 ·European Journal of Pharmacology ·Akinori Arimura,Fujio Asanuma,Hideki Yagi,Atsushi Kurosawa,Minoru Harada	22
15	Transient agonist‐like action of the thromboxane A₂ receptor antagonist S‐1452 (d‐s‐145 Ca) and its reduction by gradual injection or oral administration 1993 ·Drug Development Research ·Fujio Asanuma,Hirokuni Jyoyama,Atsushi Kurosawa	2
16	Antithrombotic action of the orally available thromboxane A₂ receptor antagonist S‐1452 (d‐s‐145 Ca) in rodents 1993 ·Drug Development Research ·Hirokuni Jyoyama,Yozo Hori,(unknown),Fujio Asanuma,Atsushi Kurosawa	2
17	Antiasthmatic Activity of a Novel Thromboxane A<sub>2</sub> Antagonist, S-1452, in Guinea Pigs 1992 ·International Archives of Allergy and Immunology ·Akinori Arimura,Fujio Asanuma,Atsushi Kurosawa,Minoru Harada	22
18	459 Pharmacologic profiles of S-1452, a novel thromboxane A2 antagonist, as an anti-asthmatic drug 1991 ·Journal of Allergy and Clinical Immunology ·Akinori Arimura,Fujio Asanuma,Akira Kurosawa,(unknown),Hiroichi Nagai,Akihide Koda	3
19	Studies on fused indoles. II. Structural modifications and analgesic activity of 4-aminomethyltetrahydrothiopyrano(2,3-b)indoles. 1984 ·Chemical and Pharmaceutical Bulletin ·Susumu Takada,(unknown),(unknown),Yasuo Makisumi,Hirokuni Jyoyama,(unknown),Fujio Asanuma,Katsumi Hirose	50
20	Pharmacological properties of 2-[4-(2-thiazolyloxy)-phenyl]-propionic acid (480156-S), a new non-steroidal antiinflammatory agent. 1984 ·PubMed ·K. Hirose,Hirokuni Jyoyama,(unknown),(unknown),(unknown),Fujio Asanuma,Hisanori Umehara,Toru Yamaguchi	22

About Fujio Asanuma

Fujio Asanuma is a scholar working on Pharmacology, Immunology and Allergy and Physiology, having authored 20 papers that have together received 472 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (14 papers), Inflammatory mediators and NSAID effects (11 papers) and Respiratory and Cough-Related Research (4 papers). The work is most often cited by research in Immunology and Allergy (82 citations), Pharmacology (168 citations) and Physiology (210 citations). Fujio Asanuma has collaborated with scholars based in Japan and United States. Frequent co-authors include Akinori Arimura, Kiyoshi Yasui, Mitsuaki Ohtani, Junji Kishino, Atsushi Kurosawa, Shinji Kakudo, Hiroshi Hasegawa, Hitoshi Arita, Hirokuni Jyoyama and Minoru Harada. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact